Please provide your email address to receive an email when new articles are posted on . Drugs that treat systemic diseases can be lifesaving, but when these drugs lead to poor ocular health or vision, ...
A new study headed by teams at the Wellcome Sanger Institute, EMBL’s European Bioinformatics Institute (EMBL-EBI), and Open Targets has indicated how mutations that cause cancer drug resistance fall ...
This systematic literature review reports incidence of adverse drug effects associated with guideline-directed medical therapy for patients with heart failure with reduced ejection fraction.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results